GlaxoSmithKline Reports Strong Q2 Growth on Vaccine and Specialty Medicines Demand
Please note that we are not authorised to provide any investment advice. The content on this page is for information purposes only. GlaxoSmithKline plc (GSK) announced strong second-quarter results on July 7, driven by robust sales of vaccines and …